Pliny the Elder, “The Natural History,” in: Bostock, J., ed., (London: Taylor and Francis, 1855): 19:54, available at <http://data.perseus.org/citations/urn:cts:latinLit:phi0978.phi001.perseus-eng1:19.54> (last accessed March 17, 2018).Google Scholar

Clark, M.M. et al., “A Meta-analysis of the Diagnostic Sensitivity and Clinical Utility of Genome Sequencing, Exome Sequencing and Chromosomal Microarray in Children with Suspected Genetic Diseases,” BioRxiv pre-print January 30, 2018, available at <https://doi.org/10.1101/255299> (last visited March 18, 2018); Z. Stark et al., “Meeting the Challenges of Implementing Rapid Genomic Testing in Acute Pediatric Care,” Genetics in Medicine 3 (2018): 1-10.+(last+visited+March+18,+2018);+Z.+Stark+et+al.,+“Meeting+the+Challenges+of+Implementing+Rapid+Genomic+Testing+in+Acute+Pediatric+Care,”+Genetics+in+Medicine+3+(2018):+1-10.>Google Scholar

Green, R.C. et al., “ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing,” Genetics in Medicine 15, no. 7 (2013): 565-574; ACMG Board of Directors, “ACMG Policy Statement: Updated Recommendations Regarding Analysis and Reporting of Secondary Findings in Clinical Genome-scale Sequencing,” Genetics in Medicine 17, no. 1 (2015): 68-69.Google Scholar

Amendola, L.M. et al., “Actionable Exomic Incidental Findings in 6503 Participants: Challenges of Variant Classification,” Genome Research 25, no. 3 (2015): 305-315; S.S. Kalia et al., “Recommendations for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing, 2016 Update (ACMG SF v2.0): a Policy Statement of the American College of Medical Genetics and Genomics,” Genetics in Medicine 19, no. 2 (2017): 249-255.Google Scholar

Wetterstrand, K.A., “DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP),” available at <www.genome.gov/sequencingcosts-data> (last accessed March 17, 2018)+(last+accessed+March+17,+2018)>Google Scholar

Ray, T., “UCSF Opens Preventive Genomics Clinic to Support Patients After Online Genetic Testing,” Genomeweb February 2, 2018, available at <https://www.genomeweb.com/molecular-diagnostics/ucsf-opens-preventive-genomics-clinic-support-patients-after-online-genetic#.Wq7GiajwaUk> (last accessed March 18, 2018).+(last+accessed+March+18,+2018).>Google Scholar

Small, A.M., O’Donnell, C.J., and Damrauer, S.M., “Large-Scale Genomic Bio-banks and Cardiovascular Disease,” Current Cardiology Reports 20, no.4 (2018): 1-9.Google Scholar

Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital, available at <http://mrctcenter.org/projects/return-of-individual-results/> (last accessed March 17, 2018).+(last+accessed+March+17,+2018).>Google Scholar

Heger, M., “Large-Scale Sequencing Projects Navigate Grey Area Between Research, Clinical Testing,” Genomeweb, January 26, 2018, available at <https://www.genomeweb.com/sequencing/large-scale-sequencing-projects-navigate-grey-area-between-research-clinical-testing#.Wq7BDqjwaUk> (last accessed March 17, 2018).+(last+accessed+March+17,+2018).>Google Scholar

U.S. Preventive Services Task Force (USPSTF), “Final Recommendation Statement: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing,” December 2013, available at <https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing (last accessed March 17, 2018).Google Scholar

Buchanan, A.H. et al., “Early Cancer Diagnoses Through BRCA1/2 Screening of Unselected Adult Biobank Participants,” Genetics in Medicine 20, no. 5 (2018): 554-558.Google Scholar

Welch, H.G. and Brawley, O.W., “Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors,” Annals of Internal Medicine 168, no. 2 (2018): 143-144.Google Scholar

Trivedi, B.P., “Is Health Care Ready for Routine DNA Screening? A Massive New Trial Will Find Out,” ScienceMag October 26, 2017, available at <http://www.sciencemag.org/news/2017/10/health-care-ready-routine-dna-screening-massive-new-trial-will-find-out> (last accessed March 18, 2018).+(last+accessed+March+18,+2018).>Google Scholar

Fossey, R. et al., “Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience,” Journal of Personalized Medicine 8, no. 2 (2018): 1-18.Google Scholar

Personal communication to author from Deborah Miller, Adam Buchanan, Amy Sturm, and David Ledbetter of Geisinger Health System, March 6, 2018.Google Scholar

Hoskovec, J.M. et al., “Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study,” Journal of Genetic Counseling 27, no. 1 (2018): 16-20.Google Scholar

Curtin, C., “Web-Based Return of Genetic Testing Results Shows Promise in Study,” GenomeWeb, February 7, 2018, available at <https://www.genomeweb.com/sequencing/web-based-return-genetic-testing-results-shows-promise-study#.Wq69xajwaUk> (last accessed March 18, 2018).+(last+accessed+March+18,+2018).>Google Scholar

Fossey, supra note 14.Google Scholar

Seegal, D., “Less May be More: Reminiscences on the Educational Impact of Some Pertinent and Pithy Remarks by my Teachers,” Journal of Chronic Diseases 16, no. 5 (1963): 441-444.Google Scholar

Rehm, H.L. et al., “ACMG Clinical Laboratory Standards for Next-Generation Sequencing,” Genetics in Medicine, September 15, no. 9 (2013): 733-747.Google Scholar

Richards, S. et al., “Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology,” Genetics in Medicine 17, no. 5 (2015): 405-424.Google Scholar

Kalia et al., supra note 4.Google Scholar

Adams, M.C., Evans, J.P., Henderson, G.E., Berg, J.S., “The Promise and Peril of Genomic Screening in the General Population,” Genetics in Medicine 18, no. 6 (2016): 593-599.Google Scholar

Morgan, T.M., “Genetic Testing for Rare and Undiagnosed Diseases,” in: David, S.P., ed., Genomic and Precision Medicine (London: Academic Press, 2017): 59-71.Google ScholarPubMed

Yang, R.Q. et al., “New Population-based Exome Data Question the Pathogenicity of Some Genetic Variants Previously Associated with Marfan Syndrome,” BMC Genetics 15, no. 74 (2014): 1-8.Google Scholar

Groth, K.A. et al., “Difficulties in Diagnosing Marfan Syndrome Using Current FBN1 Databases,” Genetics in Medicine 18, no. 1 (2016): 98-102; K.A. Groth et al., “Evaluating the Quality of Marfan Genotype-phenotype Correlations in Existing FBN1 Databases,” Genetics in Medicine 19, no. 7 (2017): 772-777.Google Scholar

De Backer, J. et al., “Utility of Molecular Analyses in the Exploration of Extreme Intrafamilial Variability in the Marfan syndrome,” Clinical Genetics 72, no. 3 (2007): 188-198.Google Scholar

Bastarache, L. et al., “Phenotype Risk Scores Identify Patients with Unrecognized Mendelian Disease Patterns,” Science 359, no. 6381 (2018): 1233–1239.Google Scholar

Prince, A.E., “Prevention for Those Who Can Pay: Insurance Reimbursement of Genetic-Based Preventive Interventions in the Liminal State Between Health and Disease,” Journal of Law and Bioscience 2, no. 2 (2015): 365-395.Google Scholar

Trivedi, supra note 13.Google Scholar

Ackerman, J.P. et al., “The Promise and Peril of Precision Medicine: Phenotyping Still Matters Most,” Mayo Clinic Proceedings 91, no. 11 (2016): 1606-1616.Google Scholar

Ashford, M., “LawSeq Effort Aims to Clarify Issues of Consent, Standards, and Liability in Genomic Medicine,” Genomeweb, July 5, 2016, available at <https://www.genomeweb.com/sequencing/lawseq-effort-aims-clarify-issues-consent-standards-and-liability-genomic-medicine#.Wq6Jj6jwaUk> (last visited March 18, 2018).+(last+visited+March+18,+2018).>Google Scholar

Vassy, J.L. et al., “The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial,” Annals of Internal Medicine 167 (2017): 159-169.Google Scholar

Rothstein, M.L., “The Case against Precipitous, Population-Wide, Whole-Genome Sequencing” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 682-689.Google Scholar

Khoury, M.J., “No Shortcuts on the Long Road to Evidence-Based Genomic Medicine,” JAMA 318, no. 1 (2017): 27-28.Google Scholar